Carbozest 450mg Injection

About

Carbozest 450mg Injection is a platinum-based chemotherapy agent widely used in the treatment of various solid tumors. It functions by forming cross-links in DNA, which ultimately inhibits DNA synthesis and function, leading to the death of rapidly dividing cancer cells. This mechanism of action makes it a potent cytotoxic agent. Carbozest is frequently employed as a cornerstone in combination chemotherapy regimens for cancers such as ovarian, lung, head and neck, and testicular cancers. Its efficacy is well-established, and it is often preferred over other platinum agents due to a generally more manageable toxicity profile, particularly regarding nephrotoxicity. Administered intravenously under strict medical supervision, it aims to achieve tumor regression, control disease progression, and improve patient survival and quality of life. Close monitoring of blood counts and renal function is crucial during treatment.

Uses

• Treatment of advanced ovarian cancer
• Management of non-small cell lung cancer
• Therapy for head and neck squamous cell carcinoma
• Eradication of testicular germ cell tumors

Directions For Use

Administer intravenously under the supervision of a qualified oncologist. Dosage is calculated based on patient's body surface area or AUC, and renal function.

Benefits

• Effective against a wide range of solid tumors
• Often used as a cornerstone in combination regimens
• Well-established efficacy in various cancer types
• Generally more manageable toxicity profile than cisplatin
• Helps improve disease control and progression-free survival
• Contributes to extending overall patient survival

Side Effects

• Myelosuppression (thrombocytopenia, leukopenia, anemia)
• Nausea and vomiting (often severe)
• Peripheral neuropathy (nerve damage)
• Ototoxicity (hearing impairment)
• Alopecia (hair loss)
• Fatigue
• Allergic reactions (hypersensitivity)
• Elevated liver enzymes
• Kidney dysfunction (nephrotoxicity)
• Electrolyte disturbances (e.g., hypomagnesemia)
• Mucositis
• Diarrhea

Safety Measures

• Alcohol - Avoid alcohol during treatment as it can exacerbate nausea, fatigue, and potential liver toxicity.
• Pregnancy - Contraindicated; highly teratogenic. Effective contraception is mandatory for both male and female patients during and for a period after treatment.
• Breastfeeding - Contraindicated; the drug is excreted in breast milk and can cause serious adverse effects in infants.
• Liver - Use with caution in patients with liver impairment; monitor liver function closely throughout treatment.
• Kidney - Use with extreme caution in patients with renal impairment; dose adjustment is crucial based on creatinine clearance.
• Lung - Monitor for pulmonary fibrosis, especially in patients with pre-existing lung conditions or prior radiation therapy to the chest.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.